The Synonymous Isocitrate Dehydrogenase 1 315C>T SNP Confers an Adverse Prognosis in Egyptian Adult Patients with NPM1-/CEBPA-Negative Acute Myeloid Leukemia.

about

The Synonymous Isocitrate Dehydrogenase 1 315C>T SNP Confers an Adverse Prognosis in Egyptian Adult Patients with NPM1-/CEBPA-Negative Acute Myeloid Leukemia.

Item

http://www.wikidata.org/entity/Q52603735

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@en

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@nl

type

Item

label

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@en

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@nl

prefLabel

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@en

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@nl

P1476

The Synonymous Isocitrate Dehy ...... gative Acute Myeloid Leukemia.

@en

P2093

Mohamed A M Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Recurring mutations found by sequencing an acute myeloid leukemia genome

IDH1 and IDH2 mutations in gliomas

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.

Haploview: analysis and visualization of LD and haplotype maps

P2888

s12288-017-0852-6

P304

240-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-017-0852-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emad Khairy Ahmed

Reham Helwa

Magda Assem

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29622865

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5884974

http://www.w3.org/2001/XMLSchema#string